{
    "organizations": [],
    "uuid": "7980058b62e64dacdce3549230b54ee57f7e72c7",
    "author": "",
    "url": "https://www.reuters.com/article/brief-alkermes-ceo-says-does-not-believe/brief-alkermes-ceo-says-does-not-believe-additional-trials-of-depression-drug-necessary-idUSFWN1RF09X",
    "ord_in_thread": 0,
    "title": "BRIEF-Alkermes CEO Says Does Not Believe Additional Trials Of Depression Drug Necessary",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 2, 2018 / 3:29 PM / in 27 minutes BRIEF-Alkermes CEO Says Does Not Believe Additional Trials Of Depression Drug Necessary Reuters Staff 1 Min Read \nApril 2 (Reuters) - Alkermes Plc: \n* CEO SAYS “WE DON’T BELIEVE ANY ADDITIONAL CLINICAL TRIALS ARE NECESSARY” ON CONF CALL WHEN ASKED ABOUT FDA’S DECISION ON ITS DEPRESSION DRUG‍​ Further company coverage:",
    "published": "2018-04-02T18:28:00.000+03:00",
    "crawled": "2018-04-02T18:59:01.058+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "pm",
        "minute",
        "ceo",
        "say",
        "believe",
        "additional",
        "trial",
        "depression",
        "drug",
        "necessary",
        "reuters",
        "staff",
        "min",
        "read",
        "april",
        "reuters",
        "alkermes",
        "plc",
        "ceo",
        "say",
        "believe",
        "additional",
        "clinical",
        "trial",
        "necessary",
        "conf",
        "call",
        "asked",
        "fda",
        "decision",
        "depression",
        "company",
        "coverage"
    ]
}